Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Cease Plasma-Derived Product Quarantine For CJD Investigations

Executive Summary

FDA will immediately release blood products quarantined for Creutzfeldt-Jakob Disease investigation, Office of Blood Research and Review Director Jay Epstein, MD, told the HHS Advisory Committee on Blood Safety and Availability Aug. 27. FDA had required manufacturers to quarantine blood and plasma-derived products while the agency investi- gated whether a donor to the blood pool from which the product was made was at increased risk of CJD.
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS032743

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel